Diabetes research and clinical practice

[1] COVID-19 and diabetes management: What should be considered?

[2] Prevention of cardiac allograft vasculopathy - A new possible indication for SGLT-2 inhibitors?

[3] SGLT-2 Inhibition and the Endocrine Pancreatic Alpha Cell: Direct or Indirect Mechanisms of Inhibition?

[4] the sglt-2 inhibitor dapagliflozin has a therapeutic effect on atherosclerosis in diabetic apoe−/− mice